⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RPRX News
Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform
globenewswire.com
RPRX
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing
globenewswire.com
RPRX
ZYME
Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing
globenewswire.com
RPRX
ZYME
Royalty Pharma to Present at TD Cowen’s 46th Annual Health Care Conference
globenewswire.com
RPRX
Parks Associates' 30th CONNECTIONS™: The Premier Connected Home Conference, May 5-7 in Santa Clara, to Unite Industry Leaders on AI, Smart Energy, Security, Broadband, Insurance, and Next-Gen Connected Living
prnewswire.com
ALRM
CALX
CHCO
AMZN
GOOG
CRM
GNTX
NRG
RJF
RPRX
SI
VIV
Royalty Pharma Reports Q4 and Full Year 2025 Results
globenewswire.com
RPRX
Enterprise and Industrial Automation Teleoperation and Telerobotics Technology and Solutions Market Research Report 2025-2030: Digital Twinning, Cloud Robotics, and "As-a-Service" Models Propel Growth
globenewswire.com
APPF
BOSC
GE
GOOGL
IBM
ISRG
CSCO
NVDA
AMZN
MSFT
RPRX
ETSY
ARM
EKSO
Royalty Pharma to Announce Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026
globenewswire.com
RPRX
Systemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics – Approvals of BENLYSTA and SAPHNELO, Plus a Strong Pipeline | DelveInsight
globenewswire.com
JNJ
BIIB
NVS
VTRS
RPRX
ABBV
AZN
MRK
RIGL
GSK
REGN
GILD
AMGN
LLY
BMY
XBI
IBB
Royalty Pharma to Highlight Accomplishments and Provide Business Update at 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
RPRX